Therapy Areas: Autoimmune
17 November 2017 - - US-based biotechnology company Evelo Biosciences is collaborating with Mayo Clinic to develop and commercialize monoclonal microbials for the treatment of inflammatory and neuroin...
17 November 2017 - Drug discovery company Ionis Pharmaceuticals Inc (NASDAQ:IONS) reported on Thursday the launch of an agreement to grant the license of a second orally delivered Generation 2.5 antis...
15 November 2017 - Hansa Medical AB (STO: HMED) on Tuesday reported net loss of SEK37,527,000, or SEK1.07 per diluted share, for the third quarter of 2017.This was a decline over net loss of SEK26,926...
13 November 2017 - - San Diego, California-based biopharmaceutical company Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) has completed full enrollment in the etrasimod Phase 2 study in ulcerative colitis...
13 November 2017 - Biopharmaceutical company Arena Pharmaceuticals Inc (NASDAQ:ARNA) reported on Friday the completion of full enrollment under its etrasimod Phase 2 study in ulcerative colitis (UC).U...
10 November 2017 - - US-based ImmunoMolecular Therapeutics (IM Therapeutics), a company developing personalized small molecule therapies for the treatment of genetically defined autoimmune diseases, h...